A study to assess the safety and tolerability of single and multiple doses of AZD4831 in healthy male subjects

Trial Identifier:	D6580C00001
Sponsor:	AstraZeneca
NCTID::	NCT02712372
Start Date:	June 2016
Primary Completion Date:	October 2016
Study Completion Date:	October 2016
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English translation
	German translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.